Company: TXG
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001770787-25-000018
Chunk: 73

Company: 10x Genomics, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 73
---
4.

Potential Payments Upon a Change of Control or Termination of Employment

Effective July 30, 2020, our compensation committee adopted the Severance Policy, which covers our NEOs (other than Mr. McAnear) with double trigger change of control severance benefits. As described in “Severance Arrangements—Change in Control Severance Policy,” our NEOs (other than Mr. McAnear) are eligible to receive certain severance payments and benefits under the Severance Policy upon a termination of employment by the company without cause or by the NEO for good reason within 24 months following a change in control. In the event of such a termination, each NEO (other than Mr. McAnear) is entitled to severance equal to six months of base salary, reimbursement for a portion of COBRA premiums for six months and accelerated vesting of any outstanding stock option or restricted stock unit awards. No NEO is entitled to receive any payments or benefits upon a change in control alone (without an accompanying qualifying termination).

Additionally, the stock options and RSUs granted to our NEOs (other than the awards granted to Mr. McAnear) are eligible to receive accelerated vesting (except performance stock options and PSUs), such that 100% of the then-unvested portion of the stock options will vest and become exercisable immediately prior to a change in control (as defined in the Severance Policy) if the NEO incurs a qualified termination (as defined in the Severance Policy).

We have no provisions for severance in place in the event of a termination of employment outside of a change of control for Drs. Saxonov and Hindson or Mr. Whitaker. Pursuant to his offer letter, Mr. Taich would be entitled to a lump sum severance payment equal to six months of his base salary in effect at the time of his termination, subject to his execution and non-revocation of a release of claims, if he is terminated by us without Cause (as defined in the Severance Policy) prior to August 21, 2025. Mr. McAnear's employment was terminated effective August 30, 2024 (upon which he did not receive any payments or benefits from the company) and he is not eligible for any potential payments upon a change of control, thus he is not included in the chart below.

#### 10X GENOMICS, INC.622025 PROXY STATEMENT
Termination Without Cause Or For Good Reason Upon a Change